AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
46 hedge funds and large institutions have $63.4M invested in Agile Therapeutics in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 13
3% less capital invested
Capital invested by funds: $65.5M → $63.4M (-$2.06M)
Holders
46
Holding in Top 10
4
Calls
$40K
Puts
$1K
Top Buyers
| 1 | +$1.5M | |
| 2 | +$1.25M | |
| 3 | +$385K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$235K |
| 5 |
Renaissance Technologies
New York
|
+$216K |
Top Sellers
| 1 | -$964K | |
| 2 | -$618K | |
| 3 | -$371K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$367K |
| 5 |
Barclays
London,
United Kingdom
|
-$165K |